Skip to main content
SpringerLink
Log in

Brain Glioma and Human Leukocyte Antigens (HLA) – is There an Association

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Expression of human leukocyte antigens (HLA) is important for the immune response against infectious agents and malignant cells. Association of single HLA antigens or HLA haplotypes with disease has been investigated previously, and positive correlations between HLA and some cancers, such as cervical or nasopharyngeal carcinomas have been reported. In the present study, HLA antigen frequencies of 65 adult Caucasian patients with low-grade, anaplastic, or malignant astrocytic glioma (WHO grades II–IV) were compared with 157 racially similar, asymptomatic control individuals. Both standard serologic and PCR techniques for HLA typing were employed for all patients and controls.

Our results suggest a positive association between single HLA antigens and presence of symptomatic cerebral glioma. Compared with the control population, patients positive for HLA-A*25 had a 3.0-fold increased risk of glioma (p = 0.04), patients positive for HLA-B*27, a 2.7-fold risk (p = 0.03), and patients positive for HLA-DRB1*15, a 2.2-fold risk (p = 0.03), whereas HLA-DRB1*07 was associated with a 0.4-fold decreased risk of glioma (p = 0.02). Occurrence rate of some HLA antigen combinations and estimated haplotypes was also different in glioma patients. Thus, HLA-DRB1*15:DRB5*(51) occurrence in combination with HLA-DRB1*11 was associated with a 13.4-fold increased risk of glioma (p = 0.001), and the incidence of HLA-Cw*6:DRB1*07 with a 0.2-fold decreased risk of glioma (p = 0.03).

In conclusion, single HLA antigens and their combinations and estimated haplotypes are possibly significantly more or less frequent in persons developing symptomatic cerebral glioma during their adult life, compared with asymptomatic individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shapiro WR: Current therapy for brain tumors: back to the future. Arch Neurol 56: 429–432, 1999

    Google Scholar 

  2. Bernstein M: Low-grade gliomas: in search of evidencebased treatment. Clin Neurosurg 44: 315–330, 1997

    Google Scholar 

  3. Hosli P, Sappino AP, de Tribolet N, Dietrich PY: Malignant glioma: should chemotherapy be overthrown by experimental treatments? Ann Oncol 9: 589–600, 1998

    Google Scholar 

  4. Forsyth PA, Cairncross JG: Treatment of malignant glioma in adults. Curr Opin Neurol 8: 414–418, 1995

    Google Scholar 

  5. Rainov NG, Dobberstein KU, Bahn H, Holzhausen HJ, Lautenschläger C, Heidecke V, Burkert W: Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival. J Neuro-Oncol 35: 13–28, 1997

    Google Scholar 

  6. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3: 255–268, 1993

    Google Scholar 

  7. Bateman AC, Howell WM: Human leukocyte antigens and cancer: is it in our genes? J Pathol 188: 231–236, 1999

    Google Scholar 

  8. Lechler R: HLA and disease. Academic Press Limited, London Boston San Diego New York Sydney Tokyo, 1994

    Google Scholar 

  9. Svejgaard A, Ryder LP: HLA and disease associations: Detecting the strongest association. Tiss Antigens 43: 18–27, 1994

    Google Scholar 

  10. Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann AM, Smith AG, Nisperos B, Swanson GM, Berwick M: Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiol Biomarkers Prev 5: 879–887, 1996

    Google Scholar 

  11. Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M: Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 7: 1035–1041, 1998

    Google Scholar 

  12. Wagner U, Kalthäuser S, Sauer H, Arnold S, Seidel W, Hantzschel H, Kalden JR, Wassmuth R: HLA markers and prediction of clinical course on outcome in rheumatoid arthritis. Arthrit Rheumatism 40: 341–351, 1997

    Google Scholar 

  13. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM: High association of an HL-A antigen, W 27, with ankylosing spondylitis. New Engl J Med 288: 704–706, 1973

    Google Scholar 

  14. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K: The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 123: 70–75, 1997

    Google Scholar 

  15. Sanjeevi CB, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Angstrom T, Dillner J, Lernmark A: Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and sero-negative Swedishwomen. Int J Cancer 68: 409–414, 1996

    Google Scholar 

  16. Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C, Goodfellow PN, Compston A: HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 2: 24–33, 1998

    Google Scholar 

  17. Takai N, Yoshida S, Hara N, Saito T, Kamoya K, Tanaka R: Investigation of HLA in patients with glioma. No To Shinkei 38: 741–745, 1986

    Google Scholar 

  18. Nitta T, Ebato M, Sato K: Association of malignant glioma with the human leukocyte antigen, HLA-A24(9). Neurosurg Rev 17: 211–215, 1994

    Google Scholar 

  19. De Moerloose P, Jeannet M, Martin-Achard A, De Tribolet N, Seiler R, Guanella N: HLA and glioma. Tiss Antigens 12: 146–148, 1978

    Google Scholar 

  20. Olerup O, Zitterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor–recipient matching in cadaveric transplantation. Tiss Antigens 39: 225–235, 1992

    Google Scholar 

  21. Terasaki PI, McClelland JD: Microdroplet assay of human serum cytotoxins. Nature 204: 998–1000, 1964

    Google Scholar 

  22. Dyer P, Warrens A: Design and interpretation of studies of the major histocompatibility complex in disease. In: Lechler R (ed) HLA and disease. Academic Press Limited, London Boston San Diego New York Sydney Tokyo, 1994, pp 93–122

    Google Scholar 

  23. Agresti A: A Survey of Exact Inference for Contingency Tables. Statistical Science 7: 131–177, 1992

    Google Scholar 

  24. Rosner B: Fundamentals of biostatistics. PWS Publishers, Boston, 1986

    Google Scholar 

  25. Mattiuz PL, Ihde D, Piazza A, Cepellini R, Bodmer WF: New approaches to the population genetic and segregation analysis of the HL-A system. In: Terasaki PI (ed) Histocompatibility Testing 1970. Munksgaard, Copenhagen, Denmark, 1970, p 193

    Google Scholar 

  26. Baur MP, Danilovs JA: Population analysis of HLA-A, B, C, DR and other genetic markers. In: Terasaki PI (ed) Histocompatibility testing 1980. Munksgaard, Copenhagen, Denmark, 1980, p 955

    Google Scholar 

  27. Tiwari JL, Terasaki PI: HLA and Disease Associations. Springer, New York, 1985, p 20

    Google Scholar 

  28. Baur MP, Neugebauer M, Albert ED: Reference tables of three-locus haplotype frequencies and delta values in Caucasians, Orientals and Negroids. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility Testing 1984. Springer-Verlag, Berlin Heidelberg New York Tokyo, 1984, pp 756–760

    Google Scholar 

  29. Chan SH, Chew CT, Prasad U, Wee GB, Srinivasan N, Kunaratnam N: HLA and nasopharyngeal carcinoma in Malays. Br J Cancer 51: 389–392, 1985

    Google Scholar 

  30. Chatzipetrou MA, Tarassi KE, Konstadoulakis MM, Pappas HE, Zafirellis KD, Athanassiades TE, Papadopoulos SA, Panousopoulos DG, Golematis BC, Papasteriades CA: Human leukocyte antigens as genetic markers in colorectal carcinoma. Dis Colon Rectum 42: 66–70, 1999

    Google Scholar 

  31. Sridama V, Hara Y, Fauchet R, DeGroot LJ: Association of differentiated thyroid carcinoma with HLA-DR7. Cancer 56: 1086–1088, 1985

    Google Scholar 

  32. Romano PJ, Bartholomew M, Smith PJ, Kloszewski F, Stryker J, Houck J, Vesell ES: HLA antigens influence resistance to lung carcinoma. Hum Immunol 31: 236–240, 1991

    Google Scholar 

  33. Krul EJ, Schipper RF, Schreuder GM, Fleuren GJ, Kenter GG, Melief CJ: HLA and susceptibility to cervical neoplasia. Hum Immunol 60: 337–342, 1999

    Google Scholar 

  34. Baur MP, Neugebauer M, Deppe H, Sigmund M, Luton T, Mayr WR, Albert ED: Population analysis on the basis of deduced haplotypes from random families. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility Testing 1984. Springer-Verlag, Berlin Heidelberg New York Tokyo, 1984, pp 333–341

    Google Scholar 

  35. Mallon E, Bunce M, Wojarowska F, Welsk K: HLACw* 0602 is a susceptibility factor in type I psoriasis and evidence Ala-73 is increased in male type I psoriasis. J Invest Dermatol 109: 183–186, 1997

    Google Scholar 

  36. Demoor P, Boogaerts M, Louwagie A: More familial leukemia in patients with both and unexplained high transcortin levels and HLA antigen Cw3. Brit J Haematol 69: 225–227, 1988

    Google Scholar 

  37. James WH: Sex ratio and hormones in HLA related rheumatic diseases. Rheum Dis 50: 401–404, 1991

    Google Scholar 

  38. Gerencer M, Tajic M, Kerhin-Brkljacic V, Kastelan A: An association between serum testosterone level and HLA phenotype. Immunol Letters 4: 155–158, 1982

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interbranch HLA Laboratory/Department GHATT, Institute of Medical Immunology, Germany

    Helmut K.G. Machulla & Astrid Schaaf

  2. Department of Neurosurgery, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

    Frank Steinborn, Volkmar Heidecke & Nikolai G. Rainov

Authors
  1. Helmut K.G. Machulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank Steinborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Astrid Schaaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Volkmar Heidecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nikolai G. Rainov
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Machulla, H.K., Steinborn, F., Schaaf, A. et al. Brain Glioma and Human Leukocyte Antigens (HLA) – is There an Association. J Neurooncol 52, 253–261 (2001). https://doi.org/10.1023/A:1010612327647

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010612327647

Search

Navigation